产物详情（用途，包装等） Ranibizumab is a recombinant humanized IgG1 kappa isotype monoclonal antibody fragment designed for intraocular use. Ranibizumab binds to and inhibits the biologic activity of human vascular endothelial growth factor A (VEGF-A). Ranibizumab, which lacks an Fc region, has a molecular weight of approximately 48 kilodaltons and is produced by CHO expression system.
Ranibizumab is supplied at a concentration of 20 mg/mL as a sterile, colorless to pale yellow solution, which contains 10 mM histidine HCl, 10% α,α-trehalose dihydrate, 0.01% polysorbate 20, pH 5.5.
供应商信息
上海拓普韦尔生物医药科技有限公司
认证状态：未认证供应商
电话：+86-02158180488
地址：Room 315, Building 3, No. 1666, Xinyang Highway, Lin-gang Special Area of China (Shanghai) Pilot Free Trade Zone
区域：China 联系人：Bruce
联系人电话：+86-21-58180488
邮件：sales@topwellpharma.com
网址：http://www.topwellpharma.com
主要市场：Europe and America
IP：